Results 81 to 90 of about 16,753 (223)

Evaluation of the cardiovascular effects of varenicline in rats

Drug Design, Development and Therapy, 2015
Engin Burak Selçuk,1 Meltem Sungu,2 Hakan Parlakpinar,3 Necip Ermiş,4 Elif Taslıdere,5 Nigar Vardı,5 Murat Yalçinsoy,6 Mustafa Sagır,3 Alaaddin Polat,7 Mehmet Karatas,8 Burcu Kayhan-Tetik11Department of Family Medicine, 2Inonu University ...
Selçuk EB, Sungu M, Parlakpinar H, Ermiş N, Taslıdere E, Vardı N, Yalçınsoy M, Sagır M, Polat A, Karatas M, Kayhan-Tetik B   +10 more
doaj  

The Economic Impact of Smoking and of Reducing Smoking Prevalence: Review of Evidence [PDF]

BACKGROUND: Tobacco smoking is the cause of many preventable diseases and premature deaths in the UK and around the world. It poses enormous health- and non-health-related costs to the affected individuals, employers, and the society at large.
Brown, AK, Ekpu, VU
core   +1 more source

Association Discovery Approach in Healthcare Big Data to Identify Drug Safety and Drug Repurposing Signals

Clinical Pharmacology &Therapeutics, Volume 119, Issue 1, Page 228-240, January 2026.
Data science approaches have been increasingly implemented in healthcare big data to evaluate the safety and effectiveness of drugs. Association discovery is a data mining approach that finds potentially associated elements in high‐dimensional data. We present a novel implementation of the association discovery approach in longitudinal healthcare data ...
George S. Q. Tan, Lynn Miller, Sam Wade, Jenni Ilomäki, Dickson Lukose, Jia Rong, Geoffrey I. Webb   +6 more
wiley   +1 more source

The cost-effectiveness of smoking cessation support delivered by mobile phone text messaging: Txt2stop. [PDF]

, 2012
BACKGROUND: The txt2stop trial has shown that mobile-phone-based smoking cessation support doubles biochemically validated quitting at 6 months. This study examines the cost-effectiveness of smoking cessation support delivered by mobile phone text ...
Cairns, John, Free, Caroline, Guerriero, Carla, Roberts, Ian, Rodgers, Anthony, Whittaker, Robyn   +5 more
core   +2 more sources

Risk of Stroke in Patients With Schizophrenia, Bipolar Disorder, and Major Depressive Disorder: A Cohort Study of 183,504 Subjects

Acta Psychiatrica Scandinavica, Volume 153, Issue 1, Page 54-64, January 2026.
ABSTRACT Background Major psychiatric disorder, including schizophrenia, bipolar disorder, and major depressive disorder, has been individually associated with increased risk of stroke. However, few studies have directly compared the stroke risk across these diagnostic groups within a unified cohort framework while accounting for stroke subtypes and ...
Mao‐Hsuan Huang, Chih‐Ming Cheng, Ju‐Wei Hsu, Ya‐Mei Bai, Tung‐Ping Su, Cheng‐Ta Li, Shih‐Jen Tsai, Yee‐Lam E. Chan, Mu‐Hong Chen   +8 more
wiley   +1 more source

Economic evaluation of smoking cessation in Ontario's regional cancer programs. [PDF]

, 2018
Quitting smoking after a diagnosis of cancer results in greater response to treatment and decreased risk of disease recurrence and second primary cancers.
Cameron, Erin, Chan, Kelvin, Djalalov, Sandjar, Evans, William, Hoch, Jeffrey S, Isaranuwatchai, Wanrudee, Masucci, Lisa, Mittmann, Nicole, Peter, Alice, Rabeneck, Linda, Truscott, Rebecca   +10 more
core   +1 more source

Risk Factors for Cardiovascular and Metabolic Disease: Integrating Traditional and Novel Paradigms

iNew Medicine, Volume 1, Issue 1, December 2025.
ABSTRACT Cardiovascular and metabolic diseases (CVMD), encompassing atherosclerotic cardiovascular disease (ASCVD), heart failure, obesity, type 2 diabetes mellitus (T2DM), and metabolic dysfunction‐associated steatotic liver disease (MASLD), remain the leading global cause of morbidity and mortality.
Zhihua Wang, Shuo Chen, Suowen Xu, Jianping Weng   +3 more
wiley   +1 more source

Efficacy of Varenicline in Smoking Cessation—A Systematic Review and Meta-analysis

Journal of Indian Academy of Oral Medicine and Radiology
Background: Tobacco use is a leading cause of morbidity and mortality. Smoking cessation significantly reduces related health risks. Varenicline, a partial nicotine receptor agonist, may aid cessation by reducing cigarette consumption and dependence ...
Reethu Ravichandiran, Venkatesh Jayaraman, Ramasamy Sarvathikari, Ramya Kalyanasundaram, Vijayalakshmi Lakshmanan, Sakthivel Sambasivam   +5 more
doaj   +1 more source

Combination therapy of varenicline and bupropion in smoking cessation: A meta-analysis of the randomized controlled trials

Comprehensive Psychiatry, 2019
Background: The effects of the combination therapy of varenicline and bupropion in smoking cessation are still controversial. Methods: Databases including PubMed, EMBASE, Cochrane Library and Web of Science were scanned without time and language ...
Zhaoshuang Zhong, Shijie Zhao, Yan Zhao, Shuyue Xia   +3 more
doaj   +1 more source

Four patients with a history of acute exacerbations of COPD: implementing the CHEST/Canadian Thoracic Society guidelines for preventing exacerbations [PDF]

, 2015
This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if ...
A Singanayagam, AJ Crockett, AL Ries, AM Yohannes, C Fletcher, CE Bucknall, CM Fletcher, CP Hersh, D Brooks, DD Marciniuk, F Maltais, FA Cleutjens, G Guyatt, GJ Criner, J Chong, J Pynoos, J Strijbos, JJ Soler-Cataluna, JW Dodd, K Gruffydd-Jones, K Rockwood, K Rockwood, KH Groenewegen, L Cheyne, L Lahousse, L Puente-Maestu, LP Fried, LS Bickford, M Guell, M Stickland, M Zwerink, MM Ball, P Almagro, PG Gibson, PW Jones, S Hull, SK Park, SP Newman, T Bodenheimer, T Lee, TM Wilkinson, VS Fan, World Health Organization, Y Lacasse   +43 more
core   +1 more source